Log in
Enquire now
‌

US Patent 7595378 Human monoclonal antibodies to epidermal growth factor receptor (EGFR)

Patent 7595378 was granted and assigned to Genmab A/S on September, 2009 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
‌
Genmab A/S
0
Date Filed
December 16, 2002
0
Date of Patent
September 29, 2009
0
Patent Application Number
10320094
0
Patent Citations Received
‌
US Patent 11753476 Combination therapy for cancers with BRAF mutation
‌
US Patent 11976125 B cell maturation antigen binding proteins
0
‌
US Patent 11771762 Anti-ErbB3 antibodies and uses thereof
‌
US Patent 12084518 Trispecific binding proteins and methods of use
0
‌
US Patent 11981744 Chimeric polypeptide assembly and methods of making and using the same
0
‌
US Patent 11713358 Chimeric polypeptide assembly and methods of making and using the same
0
Patent Inventor Names
Arnout F. Gerritsen
0
Edward Halk
0
Jan G. J. van de Winkel
0
Jørgen Petersen
0
Marcus A. van Dijk
0
Ole Baadsgaard
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
7595378
0
Patent Primary Examiner
‌
Elizabeth C. Kemmerer
0

Find more entities like US Patent 7595378 Human monoclonal antibodies to epidermal growth factor receptor (EGFR)

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.